176 related articles for article (PubMed ID: 11161848)
1. Interleukin-11 receptor expression in primary ovarian carcinomas.
Campbell CL; Guardiani R; Ollari C; Nelson BE; Quesenberry PJ; Savarese TM
Gynecol Oncol; 2001 Feb; 80(2):121-7. PubMed ID: 11161848
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of the interleukin-11 receptor and evidence of STAT3 activation in prostate carcinoma.
Campbell CL; Jiang Z; Savarese DM; Savarese TM
Am J Pathol; 2001 Jan; 158(1):25-32. PubMed ID: 11141475
[TBL] [Abstract][Full Text] [Related]
3. Expression and production of interleukin 10 in human myeloma cell lines.
Otsuki T; Yamada O; Yata K; Sakaguchi H; Kurebayashi J; Yawata Y; Ueki A
Br J Haematol; 2000 Dec; 111(3):835-42. PubMed ID: 11122145
[TBL] [Abstract][Full Text] [Related]
4. Coexpression of oncostatin M and its receptors and evidence for STAT3 activation in human ovarian carcinomas.
Savarese TM; Campbell CL; McQuain C; Mitchell K; Guardiani R; Quesenberry PJ; Nelson BE
Cytokine; 2002 Mar; 17(6):324-34. PubMed ID: 12061840
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-13 receptor alpha2 chain: a potential biomarker and molecular target for ovarian cancer therapy.
Kioi M; Kawakami M; Shimamura T; Husain SR; Puri RK
Cancer; 2006 Sep; 107(6):1407-18. PubMed ID: 16902988
[TBL] [Abstract][Full Text] [Related]
6. Expression of interleukin-11 (IL-11) and IL-11 receptor alpha in human gastric carcinoma and IL-11 upregulates the invasive activity of human gastric carcinoma cells.
Nakayama T; Yoshizaki A; Izumida S; Suehiro T; Miura S; Uemura T; Yakata Y; Shichijo K; Yamashita S; Sekin I
Int J Oncol; 2007 Apr; 30(4):825-33. PubMed ID: 17332920
[TBL] [Abstract][Full Text] [Related]
7. Expression of interleukin-6, interleukin-6 receptor (gp80), and the receptor's signal-transducing subunit (gp130) in human normal pituitary glands and pituitary adenomas.
Kurotani R; Yasuda M; Oyama K; Egashira N; Sugaya M; Teramoto A; Osamura RY
Mod Pathol; 2001 Aug; 14(8):791-7. PubMed ID: 11504839
[TBL] [Abstract][Full Text] [Related]
8. Upregulation of interleukin-8 and polarized epithelial expression of interleukin-8 receptor A in ovarian carcinomas.
Ivarsson K; Ekerydh A; Fyhr IM; Janson PO; Brännström M
Acta Obstet Gynecol Scand; 2000 Sep; 79(9):777-84. PubMed ID: 10993102
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.
Pujol P; Rey JM; Nirde P; Roger P; Gastaldi M; Laffargue F; Rochefort H; Maudelonde T
Cancer Res; 1998 Dec; 58(23):5367-73. PubMed ID: 9850067
[TBL] [Abstract][Full Text] [Related]
10. Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas.
Dong Y; Kaushal A; Bui L; Chu S; Fuller PJ; Nicklin J; Samaratunga H; Clements JA
Clin Cancer Res; 2001 Aug; 7(8):2363-71. PubMed ID: 11489814
[TBL] [Abstract][Full Text] [Related]
11. Defective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancy.
Chen HF; Lin CY; Chao KH; Wu MY; Yang YS; Ho HN
J Clin Endocrinol Metab; 2002 May; 87(5):2320-8. PubMed ID: 11994383
[TBL] [Abstract][Full Text] [Related]
12. Differential expression of interleukins IL-13 and IL-15 in normal ovarian tissue and ovarian carcinomas.
Ripley D; Shoup B; Majewski A; Chegini N
Gynecol Oncol; 2004 Mar; 92(3):761-8. PubMed ID: 14984938
[TBL] [Abstract][Full Text] [Related]
13. Expression and function of pro-inflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate.
Steiner GE; Newman ME; Paikl D; Stix U; Memaran-Dagda N; Lee C; Marberger MJ
Prostate; 2003 Aug; 56(3):171-82. PubMed ID: 12772186
[TBL] [Abstract][Full Text] [Related]
14. Decreased luteinizing hormone receptor mRNA expression in human ovarian epithelial cancer.
Lu JJ; Zheng Y; Kang X; Yuan JM; Lauchlan SC; Pike MC; Zheng W
Gynecol Oncol; 2000 Nov; 79(2):158-68. PubMed ID: 11063638
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
16. Relative expression levels of Th1 and Th2 cytokine mRNA are independent prognostic factors in patients with ovarian cancer.
Kusuda T; Shigemasa K; Arihiro K; Fujii T; Nagai N; Ohama K
Oncol Rep; 2005 Jun; 13(6):1153-8. PubMed ID: 15870936
[TBL] [Abstract][Full Text] [Related]
17. Expression of interleukin-11 receptor alpha and interleukin-11 protein in the endometrium of normal fertile women and women with recurrent miscarriage.
Linjawi S; Li TC; Tuckerman EM; Blakemore AI; Laird SM
J Reprod Immunol; 2004 Dec; 64(1-2):145-55. PubMed ID: 15596233
[TBL] [Abstract][Full Text] [Related]
18. Activation of androgen receptor-associated protein 70 (ARA70) mRNA expression in ovarian cancer.
Shaw PA; Rittenberg PV; Brown TJ
Gynecol Oncol; 2001 Feb; 80(2):132-8. PubMed ID: 11161850
[TBL] [Abstract][Full Text] [Related]
19. Expression of interleukin-6, interleukin-6 receptor, and glycoprotein 130 correlates with good prognoses for patients with breast carcinoma.
Karczewska A; Nawrocki S; Breborowicz D; Filas V; Mackiewicz A
Cancer; 2000 May; 88(9):2061-71. PubMed ID: 10813718
[TBL] [Abstract][Full Text] [Related]
20. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130.
Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS
Gastroenterology; 2005 Sep; 129(3):1005-18. PubMed ID: 16143138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
